Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Palmar plantar erythrodysesthesia primary prevention
Introduction
Overview
Overview
Avoiding excessive manual work and walking, wound care to prevent infection, limb elevation, cold compresses, avoiding extreme temperatures, analgesics, and creams/emollients are suggested to prevent, delay onset, and/or decrease the severity of palmar plantar erythrodysesthesia (PPE).
Primary Prevention
Primary Prevention
A number of measures have been suggested to prevent, delay onset, and/or decrease the severity of PPE. General measures include:[1] [2] [3] [4]
- Avoiding excessive manual work and walking, to prevent excessive pressure or friction to the skin
- Wound care to prevent infection
- Limb elevation to reduce edema
- Cold compresses
- Avoiding extreme temperatures
- Analgesics
- Creams and emollients
References
References
- ↑ Baack BR, Burgdorf WH (1991). “Chemotherapy-induced acral erythema”. J Am Acad Dermatol. 24 (3): 457–61. PMID 2061446.
- ↑ Susser WS, Whitaker-Worth DL, Grant-Kels JM (1999). “Mucocutaneous reactions to chemotherapy”. J Am Acad Dermatol. 40 (3): 367–98, quiz 399-400. PMID 10071309.
- ↑ Lassere Y, Hoff P (2004). “Management of hand-foot syndrome in patients treated with capecitabine (Xeloda)”. Eur J Oncol Nurs. 8 Suppl 1: S31–40. doi:10.1016/j.ejon.2004.06.007. PMID 15341880.
- ↑ Gerbrecht BM (2003). “Current Canadian experience with capecitabine: partnering with patients to optimize therapy”. Cancer Nurs. 26 (2): 161–7. PMID 12660565.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]